Global Blood Therapeutics has a total of 874 patents globally, out of which 436 have been granted. Of these 874 patents, 71% patents are active. The United States of America is where Global Blood Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Global Blood Therapeutics.
Global Blood Therapeutics is a subpart of Pfizer was founded in 2011. Global Blood Therapeutics (GBT) is a U.S. healthcare company focused on developing treatments for blood-related diseases. Its main drug candidate, GBT440, is a once-daily oral medicine designed to treat sickle cell disease by preventing red blood cells from sickling.
The company also conducts research on treatments for hereditary angioedema. GBT holds exclusive rights to develop and market its drug candidates in the U.S., Europe, and other major markets.
Do read about some of the most popular patents of Global Blood Therapeutics which have been covered by us in this article and also you can find Global Blood Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Global Blood Therapeutics patent portfolio.
How many patents does Global Blood Therapeutics have?
Global Blood Therapeutics has a total of 874 patents globally. These patents belong to 101 unique patent families. Out of 874 patents, 627 patents are active.
How Many Patents did Global Blood Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Global Blood Therapeutics Applications Filed | Global Blood Therapeutics Patents Granted |
| 2026 | – | 12 |
| 2025 | 1 | 37 |
| 2024 | 18 | 48 |
| 2023 | 14 | 49 |
| 2022 | 104 | 60 |
| 2021 | 80 | 75 |
| 2020 | 28 | 55 |
| 2019 | 70 | 28 |
| 2018 | 67 | 30 |
| 2017 | 92 | 25 |
How many Global Blood Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Global Blood Therapeutics File in Different Countries?
Countries in which Global Blood Therapeutics Filed Patents
| Country | Patents |
| United States of America | 108 |
| Europe (EPO) | 42 |
| Japan | 38 |
| Taiwan | 36 |
| Africa | 33 |
| Singapore | 31 |
| Mexico | 30 |
| Australia | 26 |
| Israel | 26 |
| Germany | 25 |
| China | 24 |
| Argentina | 23 |
| Canada | 23 |
| Spain | 22 |
| Brazil | 22 |
| Austria | 22 |
| Hong Kong (S.A.R.) | 20 |
| India | 20 |
| Saudi Arabia | 20 |
| South Africa | 19 |
| Italy | 19 |
| Korea (South) | 17 |
| Eurasia | 15 |
| Malaysia | 13 |
| New Zealand | 10 |
| Peru | 10 |
| Kenya | 8 |
| Hungary | 8 |
| Poland | 7 |
| Denmark | 7 |
| Portugal | 7 |
| Turkey | 6 |
| Lebanon | 6 |
| Slovenia | 6 |
| Norway | 6 |
| Lithuania | 5 |
| Slovakia | 5 |
| Chile | 5 |
| Cyprus | 5 |
| Croatia | 5 |
| Russia | 4 |
| Albania | 4 |
| Pakistan | 4 |
| Uruguay | 4 |
| Serbia | 4 |
| Finland | 3 |
| Colombia | 3 |
| Malta | 3 |
| Estonia | 2 |
| Costa Rica | 2 |
| Jordan | 2 |
| Luxembourg | 1 |
| Netherlands | 1 |
| Ecuador | 1 |
| Dominican Republic | 1 |
| Indonesia | 1 |
| Philippines | 1 |
| Viet Nam | 1 |
| Republic of Moldova | 1 |
| Former Yugoslav Republic of Macedonia | 1 |
| Morocco | 1 |
| Panama | 1 |
| Paraguay | 1 |
| Belize | 1 |
| Guatemala | 1 |
| Nicaragua | 1 |
Where are Research Centers of Global Blood Therapeutics Patents Located?
10 Best Global Blood Therapeutics Patents
WO2013102142A1 is the most popular patent in the Global Blood Therapeutics portfolio. It has received 123 citations so far from companies like Merck Sharp & Dohme Corp, Bionice, Forma Therapeutics.
Below is the list of 10 most cited patents of Global Blood Therapeutics:
| Publication Number | Citation Count |
| WO2013102142A1 | 123 |
| WO2014150276A1 | 84 |
| WO2014150289A1 | 74 |
| WO2013102145A1 | 63 |
| US9018210B2 | 60 |
| WO2014150268A1 | 58 |
| WO2014150258A1 | 56 |
| US8952171B2 | 55 |
| WO2015031285A1 | 52 |
| US9422279B2 | 50 |
What Percentage of Global Blood Therapeutics US Patent Applications were Granted?
Global Blood Therapeutics (Excluding its subsidiaries) has filed 109 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 55 have been granted leading to a grant rate of 57.89%.
Below are the key stats of Global Blood Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Global Blood Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Global Blood Therapeutics (Inhouse IP Deptt) | 61 | 45.90% |
| Pfizer Inc | 42 | 82.76% |
| Alston & Bird Global Blood Therapeutics | 4 | 100.00% |
| Jones Day Gbt | 2 | 0.00% |
What are Global Blood Therapeutics key innovation segments?
What Technologies are Covered by Global Blood Therapeutics?
The chart below distributes patents filed by Global Blood Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Global Blood Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Global Blood Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Global Blood Therapeutics?
